Skip to content

B & V PHARMA

Active Risk: not assessed
Private limited companyfounded 2005active for 20 yearsHortweidenweg 52, 3520 Zonhoven, BelgiumKBO/BCE: BE 0877.584.833

Acts, filings and financial milestones

Deadline for the 2026 accounts: 31-07-2027
2026
18-06
NBB filing Annual accounts 2025 filedNBB
abbreviated format · 43 days before the deadline
2025
31-12
Financial Highest result from 2018 to 2025net €213,775 ▲66.1%
The net result of €213,775 is the highest of those years.
10-06
NBB filing Annual accounts 2024 filedPDF
abbreviated format · 51 days before the deadline
2024
29-08
NBB filing Annual accounts 2023 filedPDF
abbreviated format · 29 days late
2023
31-12
Financial Weakest financial yearnet €45,598 ▼77.4%
The net result drops to €45,598, the lowest from 2018 to 2025. It recovers the following year.
16-08
NBB filing Annual accounts 2022 filedPDF
abbreviated format · 16 days late
26-01
Gazette deed Changes of role: HELEVEN Bart (director) and JUTTEN Véronique (director)
Capital conversion · Reserve release · Capital contribution13 points ▸
  • General meeting, 19-10-2022
  • Other provision, “aanpassing statuten aan WVV en behoud rechtsvorm, statuten aanpassen en rechtsvorm behouden” (deed in Dutch)
  • Capital conversion, “statutair onbeschikbare eigen vermogensrekening” (deed in Dutch)
  • Reserve release, “opheffing statutair onbeschikbare eigen vermogensrekening, vormen en meerderheden van de statutenwijziging” (deed in Dutch)
  • Capital contribution
  • Other provision, “opheffing eigen vermogensrekening niet-opgevraagde inbrengen, opheffing” (deed in Dutch)
  • Amendment of the articles
  • Capital
  • Director resignation, HELEVEN Bart (manager)
  • Director resignation, JUTTEN Véronique (manager)
  • Director appointment, HELEVEN Bart (director (not named in the articles))
  • Director appointment, JUTTEN Véronique (director (not named in the articles))
  • The act holds 1 more point.

Open the act in the Belgian Official Gazette

2022
31-08
NBB filing Annual accounts 2021 filedPDF
abbreviated format · 31 days late
2021
27-08
NBB filing Annual accounts 2020 filedPDF
abbreviated format · 27 days late
2020
31-12
Financial Equity above €1mequity €1.1m ▲19.2%
With a profit in every financial year since 2018, equity grows to €1.1m.
07-07
NBB filing Annual accounts 2019 filedPDF
abbreviated format · 24 days before the deadline
2019
21-08
NBB filing Annual accounts 2018 filedPDF
abbreviated format · 21 days late
Show earlier events
2018
02-07
NBB filing Annual accounts 2017 filedPDF
abbreviated format · 29 days before the deadline
2017
22-08
NBB filing Annual accounts 2016 filedPDF
abbreviated format · 22 days late
2005
08-12
Gazette deed IncorporationPDF
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.

Sources:Publications in the Belgian Official GazetteFilings with the National Bank

History

B & V PHARMA was incorporated on 29 November 2005.1 Total assets went from €2.0m in 2018 to €2.1m in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2018 and 2025

Next steps